UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016857
Receipt number R000019569
Scientific Title Investigation of pulmonary hypertension in patients receiving tyrosine kinase inhibitors
Date of disclosure of the study information 2015/03/20
Last modified on 2016/01/18 11:23:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of pulmonary hypertension in patients receiving tyrosine kinase inhibitors

Acronym

TKI-induced PH

Scientific Title

Investigation of pulmonary hypertension in patients receiving tyrosine kinase inhibitors

Scientific Title:Acronym

TKI-induced PH

Region

Japan


Condition

Condition

Chronic myelogenous leukemia, Philadelphia chromosome-positive acute lymphoblastic leukemia

Classification by specialty

Medicine in general Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

To assess the incidence and frequency of pulmonary hypertension in CML or Ph-positive ALL patients taking tyrosine kinase inhibitors.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Frequency of tyrosine kinase inhibitor induced pulmonary hypertension.

Key secondary outcomes

Risk factors associated with tyrosine kinase inhibitor induced pulmonary hypertension.


Base

Study type


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Medicine

Interventions/Control_1

Tyrosine kinase inhibitor

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients under treatment with TKI at the institutions participating this investigation.

Key exclusion criteria

Unable to obtain the consent.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Koichi Akashi

Organization

Kyushu University Hospital

Division name

Department of medicine and biosystemic science

Zip code


Address

3-1-1 Maidashi, Higashi-ku, Fukuoka

TEL

0926425228

Email

toshmiya@intmed1.med.kyushu-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Toshihiro Miyamoto

Organization

Kyushu University Hospital

Division name

Department of medicine and biosystemic science

Zip code


Address

3-1-1 Maidashi, Higashi-ku, Fukuoka

TEL

092-642-5230

Homepage URL


Email

toshmiya@intmed1.med.kyushu-u.ac.jp


Sponsor or person

Institute

Kyushu university

Institute

Department

Personal name



Funding Source

Organization

Fukuoka bone marrow transplantation group

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 03 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 03 Month 20 Day

Date of IRB


Anticipated trial start date

2015 Year 03 Month 20 Day

Last follow-up date


Date of closure to data entry

2015 Year 12 Month 31 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 03 Month 20 Day

Last modified on

2016 Year 01 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019569